切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2012, Vol. 06 ›› Issue (06) : 668 -674. doi: 10.3877/cma. j. issn.1674-0807.2012.06.010

综述

微RNA 在乳腺癌发生发展中的作用
张雁磊1, 张吉强2   
  1. 1.400038 重庆,第三军医大学学员旅十队
    2.400038 重庆,第三军医大学基础医学部神经生物教研室神经生物学重庆市重点实验室
  • 收稿日期:2012-02-14 出版日期:2012-12-01

Role of microRNA in the development of breast cancer

Yan-lei ZHANG, Ji-qiang ZHANG   

  • Received:2012-02-14 Published:2012-12-01
引用本文:

张雁磊, 张吉强. 微RNA 在乳腺癌发生发展中的作用[J/OL]. 中华乳腺病杂志(电子版), 2012, 06(06): 668-674.

Yan-lei ZHANG, Ji-qiang ZHANG. Role of microRNA in the development of breast cancer[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2012, 06(06): 668-674.

[1]
Downs-Holmes C, Silverman P. Breast cancer: Overview & updates [J]. Nurse Pract,2011,36(12):20-26.
[2]
Liu J, Zheng M, Tang YL, et al. Micrornas, an active and versatile group in cancers [J]. Int J Oral Sci,2011,3(4):165-175.
[3]
Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of microrna genes mir15 and mir16 at 13q14 in chronic lymphocytic leukemia [J]. Proc Natl Acad Sci USA,2002,99(24):15 524-15 529.
[4]
Andorfer CA, Necela BM, Thompson EA, et al. Microrna signatures: Clinical biomarkers for the diagnosis and treatment of breast cancer [J]. Trends Mol Med,2011,17(6):313-319.
[5]
Iorio MV, Ferracin M, Liu CG, et al. Microrna gene expression deregulation in human breast cancer [J]. Cancer Res,2005,65(16):7065-7070.
[6]
Sempere LF, Christensen M, Silahtaroglu A, et al. Altered microrna expression confined to specific epithelial cell subpopulations in breast cancer [J]. Cancer Res,2007,67(24):11 612-11 620.
[7]
Iyevleva AG, Kuligina ES, Mitiushkina NV, et al. High level of mir-21, mir-10b, and mir-31 expression in bilateral vs.Unilateral breast carcinomas [J]. Breast Cancer Res Treat,2012,131(3):1049-1059.
[8]
Zhu N, Zhang D, Xie H, et al. Endothelial-specific intron-derived mir-126 is down-regulated in human breast cancer and targets both vegfa and pik3r2 [J]. Mol Cell Biochem,2011,351(1/2):157-164.
[9]
Ma L, Young J, Prabhala H, et al. Mir-9, a myc/mycn-activated microrna, regulates e-cadherin and cancer metastasis[J]. Nat Cell Biol,2010,12(3):247-256.
[10]
Khew-Goodall Y, Goodall GJ. Myc-modulated mir-9 makes more metastases [J]. Nat Cell Biol,2010,12(3):209-211.
[11]
Zhang X, Yu H,Lou JR,et al. Microrna-19 (mir-19) regulates tissue factor expression in breast cancer cells [J]. J Biol Chem,2011,286(2):1429-1435.
[12]
Jeyapalan Z, Deng Z, Shatseva T, et al. Expression of cd44 3′-untranslated region regulates endogenous microrna functions in tumorigenesis and angiogenesis [J]. Nucleic Acids Res,2011,39(8):3026-3041.
[13]
Yu Z,Baserga R,Chen L,et al. Microrna,cell cycle,and human breast cancer [J]. Am J Pathol,2010,176(3):1058-1064.
[14]
Huang Q, Gumireddy K, Schrier M, et al. The micrornas mir-373 and mir-520c promote tumour invasion and metastasis[J]. Nat Cell Biol,2008,10(2):202-210.
[15]
Zhu S, Wu H, Wu F, et al. Microrna-21 targets tumor suppressor genes in invasion and metastasis [J]. Cell Res,2008,18(3):350-359.
[16]
Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microrna-10b in breast cancer [J].Nature,2007,449(7163):682-688.
[17]
Shah MY, Calin GA. Micrornas mir-221 and mir-222: A new level of regulation in aggressive breast cancer [J]. Genome Med,2011,3(8):56.
[18]
Li H, Bian C, Liao L, et al. Mir-17-5p promotes human breast cancer cell migration and invasion through suppression of hbp1[J]. Breast Cancer Res Treat,2011,126(3):565-575.
[19]
Tavazoie SF, Alarcon C, Oskarsson T, et al. Endogenous human micrornas that suppress breast cancer metastasis[J].Nature,2008,451(7175):147-152.
[20]
Zhang S, Kim K, Jin UH, et al. Aryl hydrocarbon receptor agonists induce microrna-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells [J]. Mol Cancer Ther,2011,11(1):108-118.
[21]
Lv XB, Jiao Y, Qing Y, et al. Mir-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of prometastatic genes in vitro [J]. Chin J Cancer,2011,30(12):821-830.
[22]
Gregory PA, Bert AG, Paterson EL, et al. The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting zeb1 and sip1 [J]. Nat Cell Biol,2008,10(5):593-601.
[23]
Burk U, Schubert J, Wellner U, et al. A reciprocal repression between zeb1 and members of the mir-200 family promotes emt and invasion in cancer cells [J]. EMBO Rep,2008,9(6):582-589.
[24]
Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells [J]. Proc Natl Acad Sci USA,2003,100(7):3983-3988.
[25]
Greene SB, Herschkowitz JI, Rosen JM. Small players with big roles: Micrornas as targets to inhibit breast cancer progression [J]. Curr Drug Targets,2010,11(9):1059-1073.
[26]
Shimono Y, Zabala M, Cho RW, et al. Downregulation of mirna-200c links breast cancer stem cells with normal stem cells [J]. Cell,2009,138(3):592-603.
[27]
Yu F, Yao H, Zhu P, et al. Let-7 regulates self renewal and tumorigenicity of breast cancer cells [J]. Cell, 2007,131(6):1109-1123.
[28]
Yu F, Jiao Y, Zhu Y, et al. Mir-34c down-regulation via DNA methylation promotes self-renewal and epithelialmesenchymal transition in breast tumor-initiating cells [J]. J Biol Chem,2012,287(1):465-473.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[3] 刘伟, 牛云峰, 安杰. LINC01232 通过miR-516a-5p/BCL9 轴促进三阴性乳腺癌的恶性进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 330-338.
[4] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[5] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[6] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[7] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[8] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[9] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[10] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[11] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[12] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[13] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[14] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[15] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
阅读次数
全文


摘要